Analysts Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) PT at $54.82
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the twelve analysts that are covering the stock, Marketbeat.com reports. Twelve investment analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has received an average recommendation of “Buy” from the twelve analysts that are covering the stock, Marketbeat.com reports. Twelve investment analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]
